Letter from the Editor #606

We have provided a lot of information about the most current therapies for diabetes and co-morbidities in recent months and in an effort to bring you more than any other online publication we like to delve into the background on these therapies and bring you information you don’t usually find anywhere else. Last week we had a special feature that Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men, and this week we want to give you information on The Safety and Extrapancreatic effects of GLP-1 on cardiovascular tissue, adipose tissue, liver, and kidney.

This week, Items #7, Medication Combo Improved Weight Loss When Added To Lifestyle Modifications, and #8, Link Between Bio-clock, Glucose Metabolism Found, talk about reasons for increased weight and new drugs that can reduce weight. These two articles could not come at a better time as the “season of dieting” begins.

*****

Announcements:

NEW CME available! 13 AMA PRA Category 1 Credits are now available from CardioCareLive. See our CME page for all of CardioCareLive’s enduring CME available.

Please answer this week’s poll: How many of your patients will be successful with their New Year’s resolutions?

Vote in and then see results from previous polls here.

Check out this week’s “Test Your Diabetes Knowledge” question!

Dave Joffe, Editor-in-chief